TAKE CONTROL WITH RHOPRESSA®
(netarsudil ophthalmic solution) 0.02%
Get personalized support for your RHOPRESSA® treatment with the MyAlcon Together Patient Support program
How does RHOPRESSA® work?
Elevated IOP may result in glaucoma
For people with open-angle glaucoma, fluid in the eye (called aqueous humor) does not drain properly. This elevates the pressure in the eye.
How can RHOPRESSA® help?
RHOPRESSA® is a prescription medication for the reduction of high eye pressure in patients with open-angle glaucoma or ocular hypertension.
- RHOPRESSA® helps increase the flow of fluid from the eye, which can lower the eye pressure
Get more support for your RHOPRESSA® treatment by enrolling in the MyAlcon Together Patient Support program for offerings that are personalized just for you
Savings & Support
MyAlcon Together
Enroll in the MyAlcon Together Patient Support program and choose customized support options that fit your needs:
- MyAlcon Together nurses can provide telephone support and education in over 200 languages to answer general questions about glaucoma and your IOP-lowering treatment
- Savings on your RHOPRESSA® prescription (for eligible, commercially insured patients)
- Text or email reminders about topics like properly administering your medication, remembering prescription refills, and other useful resources
Resources
Glaucoma Glossary
Learn some of the common terms you may often see when reading about glaucoma.
Guide to Open-Angle Glaucoma
A short guide to help you better understand your condition.
Learn more about open-angle glaucoma
American Academy of Ophthalmology
How do I use RHOPRESSA®?
RHOPRESSA® should be taken once daily in the evening
- The recommended dose for RHOPRESSA® is one drop in the affected eye(s) once daily in the evening
- If you miss a dose of RHOPRESSA®, you should continue with your next dose the following evening
- If more than 1 eye drop is being used, the drugs should be administered at least 5 minutes apart
- Contact lenses should be removed prior to the administration of RHOPRESSA® and may be reinserted 15 minutes after administration
Storing RHOPRESSA®
- Keep the RHOPRESSA® bottle in the refrigerator (36 °F to 46 °F) until opened
- After opening, RHOPRESSA® may be kept at 36 °F to 77 °F for up to 6 weeks
- If after opening, RHOPRESSA® is kept refrigerated at 36 °F to 46 °F, then the product can be used until the expiration date stamped on the bottle
IOP=Intraocular pressure.
INDICATION
What is RHOPRESSA®?
RHOPRESSA® (netarsudil ophthalmic solution) 0.02% is a prescription medicine to reduce high eye pressure (intraocular pressure, or IOP) in patients with open-angle glaucoma or ocular hypertension.
IMPORTANT SAFETY INFORMATION
- Avoid allowing the tip of the bottle to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solution.
- If you develop another ocular condition (e.g., trauma or infection, or decreased vision with or without eye pain), have ocular surgery, or develop any ocular side effects, particularly conjunctivitis and eyelid reactions, you should immediately seek your healthcare provider’s advice about continuing to use RHOPRESSA®.
- The preservative in RHOPRESSA®, benzalkonium chloride, may be absorbed by soft contact lenses. Contact lenses should be removed prior to instillation of RHOPRESSA®, but may be reinserted 15 minutes after instillation.
- If you are using more than one eyedrop, the drugs should be administered at least 5 minutes apart.
- The most common side effect of RHOPRESSA® in clinical trials was red eyes (53% of patients). Six percent of patients stopped taking RHOPRESSA® due to red eyes. Other common (approximately 20%) side effects were: small deposits on the outer surface of the eye, instillation site pain, and broken blood vessels on the white of the eye.
For additional information about RHOPRESSA®, talk to your healthcare provider and click here to see the full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.